Robert R. Seltzer, Director, 10% Owner at NephroGenex, Inc. (NRX), bought 1,680,140 shares at $12.00 ($9.5M) on 2014-02-14, disclosed to the SEC on 2014-02-19.
Open-market purchase of $9.5M NRX by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 890,140 | $0 | 0.0% |
| 2 | $12.00 | 790,000 | $9.5M | 100.0% |
| Total | $5.64 avg | 1,680,140 | $9.5M | 100% |